Medtronic, Bayer expand diabetes deal into U.S.

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Medtronic and Tarrytown, N.Y.-based Bayer HealthCare have expanded their international alliance to include the U.S., and will work exclusively to develop diabetes management technologies for patients and wireless blood glucose meters for the global market.

Since 2007, the two companies have collaborated internationally by providing Bayer’s Countor Link meter to people with diabetes who use compatible MiniMed Paradigm insulin pumps and the Guardian continuous glucose monitoring (CGM) system from the Minneapolis-based Medtronic.